doi: 10.1503/cmaj.140495 196 StatsenkoMETurkinaSV
Almost 50% of people taking GLP-1 medication think it's okay to ask someone about their use of weight-loss medication, but only in certain situations, such as: Close personal relationships: 64% Concern for health: 62% Professional/healthcare settings: 60% If they have posted about their weight loss journey online: 40% 3 in 4 people taking GLP-1 medication are transparent about their weight-loss medication use
For Florida residents, prescriptions may be issued through telehealth following a medical evaluation in accordance with Florida telehealth laws
By promoting weight reduction, semaglutide indirectly aids in improving insulin sensitivity, which further supports blood sugar control
The getting started with peptides resource emphasizes this principle across all peptide protocols
These assessments identify contraindications, establish baseline metrics, and inform dosing decisions